At-Home Genetic Testing Goes Beyond Just DNA


The Dave and Dave Show looks at 23andMe’s DNA test-taking kit and its recent approval by the FDA to scan for certain breast cancer genes. We examine the possibilities and limitations, where the market is headed, and what it means for the biotech industry and its business advisors.


Dave Plaskow: Hello and welcome to EisnerAmper’s technology podcast series. 

David Katz is a Senior Audit Manager providing domestic and international accounting, auditing and business consulting services to public and private clients in a variety of industries.

Contact David

* Required